Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma—An Overview

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third highest cause of mortality from cancer, largely because of delays in diagnosis. There is currently no effective therapy for advanced stage HCC, although sorafenib, the standard treatment for HCC, systemic therapy (including...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Agnano, Igea, Berardi, Anna Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072503/
https://www.ncbi.nlm.nih.gov/pubmed/31973229
http://dx.doi.org/10.3390/cancers12020261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072503/
https://www.ncbi.nlm.nih.gov/pubmed/31973229
http://dx.doi.org/10.3390/cancers12020261

Ejemplares similares